|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,484.35 INR | -1.57% |
|
-6.11% | -6.76% |
| 20/11 | Hester Biosciences says Ashish Desai appointed as chief financial officer | RE |
| 20/11 | Hester Biosciences Appoints CFO | MT |
| Capitalization | 1.26TCr 14Cr 12Cr 11Cr 10Cr 19Cr 21Cr 128.48Cr 51Cr 604.04Cr 52Cr 51Cr 2.21TCr | P/E ratio 2024 |
62.6x | P/E ratio 2025 | 38.8x |
|---|---|---|---|---|---|
| Enterprise value | 1.48TCr 16Cr 14Cr 13Cr 12Cr 23Cr 25Cr 150.5Cr 59Cr 707.55Cr 61Cr 60Cr 2.59TCr | EV / Sales 2024 |
4.53x | EV / Sales 2025 | 4.11x |
| Free-Float |
32.76% | Yield 2024 |
0.43% | Yield 2025 | 0.56% |
More valuation ratios
* Estimated data
More news
Last Transcript: Hester Biosciences Limited
| 1 day | -1.57% | ||
| 1 week | -6.11% | ||
| Current month | -6.76% | ||
| 1 month | -7.64% | ||
| 3 months | -12.54% | ||
| 6 months | -17.88% | ||
| Current year | -6.76% |
| 1 week | 1,482.05 |  | 1,616.65 |
| 1 month | 1,482.05 | | 1,649 |
| Current year | 1,482.05 | | 1,649 |
| 1 year | 1,246.75 | | 2,347.7 |
| 3 years | 1,246.75 | | 3,375.45 |
| 5 years | 1,246.75 | | 3,375.45 |
| 10 years | 337 | | 3,375.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 29/04/1987 | |
Vinod Mali
CMP | Compliance Officer | - | 14/05/2018 |
Sumit Gupta
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2008 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 28/10/2021 | |
| Chairman | 83 | 21/04/2005 | |
| Director/Board Member | 63 | 29/04/1987 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.57% | -6.11% | -32.71% | -16.24% | 14Cr | |
| +0.98% | -2.71% | -24.34% | -21.80% | 5.49TCr | |
| -0.04% | +2.69% | +108.89% | +86.85% | 1.21TCr | |
| -1.10% | -1.53% | -22.53% | +4.89% | 402.18Cr | |
| -0.28% | +1.41% | +14.81% | +42.49% | 352.45Cr | |
| -0.29% | +7.45% | +172.01% | +67.64% | 271.77Cr | |
| -2.07% | +4.33% | -16.20% | +3.71% | 183.62Cr | |
| -1.46% | +0.83% | +96.69% | +171.41% | 164Cr | |
| -0.55% | +1.27% | +15.29% | +4.79% | 130.31Cr | |
| -1.61% | +0.13% | +28.16% | -37.69% | 117.83Cr | |
| Average | -0.80% | +1.42% | +34.01% | +30.61% | 834.31Cr | |
| Weighted average by Cap. | +0.46% | +1.39% | +7.10% | +5.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 311.19Cr 3.45Cr 2.96Cr 2.75Cr 2.56Cr 4.78Cr 5.16Cr 32Cr 12Cr 148.86Cr 13Cr 13Cr 545.48Cr | 312.47Cr 3.46Cr 2.97Cr 2.77Cr 2.57Cr 4.8Cr 5.18Cr 32Cr 13Cr 149.48Cr 13Cr 13Cr 547.72Cr |
| Net income | 19Cr 20.92L 17.95L 16.72L 15.56L 29.03L 31.3L 1.92Cr 75.61L 9.04Cr 78.47L 76.86L 33Cr | 27Cr 30.45L 26.13L 24.33L 22.64L 42.25L 45.54L 2.8Cr 1.1Cr 13Cr 1.14Cr 1.12Cr 48Cr |
| Net Debt | 229.07Cr 2.54Cr 2.18Cr 2.03Cr 1.89Cr 3.52Cr 3.8Cr 23Cr 9.17Cr 109.58Cr 9.52Cr 9.32Cr 401.53Cr | 216.39Cr 2.4Cr 2.06Cr 1.92Cr 1.78Cr 3.33Cr 3.59Cr 22Cr 8.66Cr 103.51Cr 8.99Cr 8.8Cr 379.3Cr |
More financial data
* Estimated data
Employees
562
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | 1,484.35 ₹ | -1.57% | 162 |
| 13/26/13 | 1,508.05 ₹ | -2.35% | 232 |
| 12/26/12 | 1,544.35 ₹ | -0.85% | 494 |
| 09/26/09 | 1,557.60 ₹ | -2.15% | 76 |
| 08/26/08 | 1,591.80 ₹ | -2.08% | 225 |
Delayed Quote Bombay S.E., January 14, 2026 at 03:30 pm IST
More quotes
Annual profits - Rate of surprise
- Stock Market
- Equities
- 524669 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition